Diabetic Care Market has recently added a report Forecast to 2028 to its repository, which comprises of data relating to the market size, share, value, and volume, production processes, revenue generation, the regional analysis of the business vertical, along with the outcomes of analytical tools including, SWOT analysis and Porter’s Five Forces analysis. The report highlights the growth opportunities and challenges that industry players might encounter in the forecast years, along with an elaborate competitive landscape and expansion strategies adopted by the companies functioning in the Keyword Market.

It assesses the present market scenario and forecasts the pandemic’s aftermath in this business sector to help organizations boost their COVID-19 preparedness. The market intelligence report takes a closer view of the global market share, estimated growth rate, future market trends, entry-level barriers, fundamental market drivers, restraints, challenges, and opportunities. The report clearly defines the Diabetic Care market position on a global level. The detailed insights into the market’s geographical spectrum offered by the report make it an excellent source of knowledge about the Diabetic Care industry.

The report is updated with the latest economic scenario and market scope with regard to the ongoing COVID-19 pandemic. The report covers growth prospects as well as current and futuristic revenue estimations in a post COVID scenario. The report also covers changing trends and market dynamics due to the pandemic and provides an accurate impact analysis of the crisis on the overall market.

 Get a sample of the report : https://www.emergenresearch.com/request-sample/180

Global Diabetes Care Market revenue growth is expected to be driven by key factors such as increasing prevalence of diabetes worldwide, rising awareness regarding benefits of diabetes treatment and management, and favorable government initiatives in various countries. In addition, technological advancements in medical devices and solutions, and rising prevalence of obesity are factors driving revenue growth of the market.

However, significant shortage of trained professional worldwide and challenges related to management of diabetes, including a lack of general awareness about diabetes and its complications among a sizable number of younger individuals, especially in remote areas are key factors expected to restrain revenue growth of the Global Diabetes Care Market to some extent.

Based on end-use, the global market is segmented into hospitals & clinics, home care settings, and diagnostic centers. The hospitals & clinics segment dominated other segments and accounted for largest revenue share in 2020. An increasing number of hospital admissions of diabetes patients is boosting growth of this segment.

North America is expected to register a steady growth rate in the Global Diabetes Care Market over the forecast period. This is due to increasing prevalence of diabetes and obesity among the aging population as well as younger individuals, and changing lifestyle.

Some major companies in the market report include Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation, Ypsomed (Switzerland), Dr. Morepen (India), Insulet, Life Scan IP holdings, and Eli Lilly and Company

In May 2021, Medtronic announced that it had received a CE mark for its InPen smart insulin pen and Guardian 4 sensor for better diabetes management.

Request a discount on the report : https://www.emergenresearch.com/request-discount/180

Emergen Research has segmented Global Diabetes Care Market on the basis of device type, distribution type, end-use, and region:

Device Type Outlook (Revenue, USD Million; 2018–2028)

• Blood Glucose Monitoring
  • Self-Monitoring Devices
    1. Blood Glucose Meters
    2. Test Strips
    3. Lancelets
  • Continuous Glucose Monitoring Devices
    1. Sensors
    2. Transmitters
    3. Receiver
• Insulin Delivery Devices
  1. Pumps
  2. Pens
  3. Syringes
  4. Jet Injectors

By Distribution Channel Outlook (Revenue, USD Million; 2018–2028)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

End-use Outlook (Revenue, USD Million; 2018–2028)

• Hospitals & Clinics
• Homecare Settings
• Diagnostic Centers

Regional Outlook (Revenue, USD Million; 2018–2028)

• North America
  1. U.S.
  2. Canada
  3. Mexico
• Europe
  1. Germany
  2. U.K.
  3. France
  4. Spain
  5. BENELUX
  6. Rest of Europe
• Asia Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Rest of APAC
• Latin America
  1. Brazil
  2. Rest of LATAM
• Middle East & Africa
  1. Saudi Arabia
  2. UAE
  3. Israel
  4. Rest Of MEA

Key Objectives of the Report:

Analysis and estimation of the Diabetic Care market size and share for the projected period of 2020-2027

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Diabetic Care market

Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments

Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Read More: https://www.emergenresearch.com/industry-report/diabetic-care-market

Related Reports:

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research  and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalnt in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs